BDTX stock · BXP stock

BDTX vs BXP · $95.7M cap vs rev $3.48B

Black Diamond Therapeutics Inc (BDTX) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.

Black Diamond Therapeutics Inc (BDTX) is a biotechnology company listed on NASDAQ.

Boston Properties Inc (BXP) is a reit - office company listed on US.

BDTX does not have a complete income-statement cache yet.

Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.

BDTX currently screens at market cap $95.7M. BXP currently screens at market cap $12.12B.

Not investment advice. Open the BDTX and BXP stock pages for the full models.

Not investment advice.

Popular Stock Comparisons